Clinical consequences of tocilizumab consumption time on COVID-19 patients

Background & Aims: Studies have shown that treating COVID-19 with tocilizumab is associated with lower death risks and mechanical ventilation needs. However, the definite effectiveness of this drug based on the timing of its use is still controversial due to various findings. Some studies have s...

Full description

Bibliographic Details

Published in:	Journal of Research in Applied and Basic Medical Sciences
Main Authors:	Shahin Keshtkar Rajabi, Amir Ziaee, Farshad Divsalar, Elnaz Hemmati, Mohammad Amin Abbasi
Format:	Article
Language:	English
Published:	Urmia University of Medical Sciences 2024-11-01
Subjects:	actemra covid-19 outcome tocilizumab treatment
Online Access:	http://ijrabms.umsu.ac.ir/article-1-289-en.pdf